Postdoc/ at the nanoprobes and nanoswitches Research Group
Postdoctoral / Deadline 23th September 2022
Nanoprobes and nanoswitches
Group
The first light-controlled drug that could improve the hearing of people with cochlear implants
Researchers at the Institute for Bioengineering of Catalonia (IBEC) in Spain and the University Medical Center Göttingen in Germany achieve, for the first time, in vivo light-activated auditory stimulation without the need for genetic manipulation. This new light-controlled drug, capable of triggering the neural pathways involved in hearing, can contribute to improving the spectral resolution of cochlear implants used by people with profound hearing loss or deafness.
ONCE visits IBEC to learn about the research in bioengineering for health
